期刊
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
卷 130, 期 38, 页码 12645-+出版社
AMER CHEMICAL SOC
DOI: 10.1021/ja805165y
关键词
-
资金
- National Institute of General Medical Sciences [R01-GM62871]
- Merck Research Laboratories
- Novartis
- National Science Foundation [CHE-0234877, CHE-9808061, DBI-9729592]
- National Institutes of Health [1S10RR13886-01]
A stereoconvergent method for the catalytic asymmetric Negishi cross-coupling of racemic secondary propargylic halides with arylzinc reagents has been developed. Neither family of compounds has previously been shown to be a suitable partner in such coupling processes. From a practical point of view, it is noteworthy that the catalyst components (NiCl2 glyme and pybox ligand 1) are commercially available.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据